Repare Therapeutics マネジメント
マネジメント 基準チェック /24
Repare Therapeuticsの CEO はLloyd Segalで、 Sep2016年に任命され、 の在任期間は 8.17年です。 の年間総報酬は$ 4.99Mで、 12.3%給与と87.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.28%を直接所有しており、その価値は$ 331.21K 。経営陣と取締役会の平均在任期間はそれぞれ5.5年と4.7年です。
主要情報
Lloyd Segal
最高経営責任者
US$5.0m
報酬総額
| CEO給与比率 | 12.3% |
| CEO在任期間 | 8.2yrs |
| CEOの所有権 | 0.3% |
| 経営陣の平均在職期間 | 5.5yrs |
| 取締役会の平均在任期間 | 4.7yrs |
経営陣の近況
Recent updates
Analysts' Revenue Estimates For Repare Therapeutics Inc. (NASDAQ:RPTX) Are Surging Higher
Nov 13
There's No Escaping Repare Therapeutics Inc.'s (NASDAQ:RPTX) Muted Revenues Despite A 35% Share Price Rise
Oct 05Repare: Q4 2024 Is A Major Inflection Point With Lunresertib, Camonsertib Data
Aug 30Will Repare Therapeutics (NASDAQ:RPTX) Spend Its Cash Wisely?
Jul 12Repare Therapeutics Inc.'s (NASDAQ:RPTX) 34% Dip In Price Shows Sentiment Is Matching Revenues
May 01Benign Growth For Repare Therapeutics Inc. (NASDAQ:RPTX) Underpins Stock's 30% Plummet
Mar 12We Think Repare Therapeutics (NASDAQ:RPTX) Needs To Drive Business Growth Carefully
Feb 15Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Fly 30% But Investors Aren't Buying For Growth
Dec 20Here's Why We're Not At All Concerned With Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation
Oct 24New Forecasts: Here's What Analysts Think The Future Holds For Repare Therapeutics Inc. (NASDAQ:RPTX)
Aug 14Analysts Are Betting On Repare Therapeutics Inc. (NASDAQ:RPTX) With A Big Upgrade This Week
May 14Analysts Are Upgrading Repare Therapeutics Inc. (NASDAQ:RPTX) After Its Latest Results
May 12Repare Therapeutics Inc. (NASDAQ:RPTX) Looks Inexpensive But Perhaps Not Attractive Enough
May 08Growth Investors: Industry Analysts Just Upgraded Their Repare Therapeutics Inc. (NASDAQ:RPTX) Revenue Forecasts By 31%
Mar 03Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth
Oct 27Repare Therapeutics: Budding Synthetic Lethality Player With 3 Big Pharma Partners
Sep 07Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06, revenue of $0.67M
Aug 04Repare Therapeutics: Interesting Gene Editing Company, But Miles To Go
Jun 27Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth
Jun 24Repare Therapeutics (NASDAQ:RPTX) Is In A Good Position To Deliver On Growth Plans
Mar 02We're Not Worried About Repare Therapeutics' (NASDAQ:RPTX) Cash Burn
Oct 14We Think Repare Therapeutics (NASDAQ:RPTX) Can Easily Afford To Drive Business Growth
Apr 16Have Repare Therapeutics Inc. (NASDAQ:RPTX) Insiders Been Selling Their Stock?
Mar 12CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$84m |
| Jun 30 2024 | n/a | n/a | -US$69m |
| Mar 31 2024 | n/a | n/a | -US$46m |
| Dec 31 2023 | US$5m | US$615k | -US$94m |
| Sep 30 2023 | n/a | n/a | -US$97m |
| Jun 30 2023 | n/a | n/a | -US$3m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$4m | US$592k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$26m |
| Jun 30 2022 | n/a | n/a | -US$132m |
| Mar 31 2022 | n/a | n/a | -US$120m |
| Dec 31 2021 | US$4m | US$572k | -US$107m |
| Sep 30 2021 | n/a | n/a | -US$94m |
| Jun 30 2021 | n/a | n/a | -US$77m |
| Mar 31 2021 | n/a | n/a | -US$62m |
| Dec 31 2020 | US$5m | US$505k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$46m |
| Jun 30 2020 | n/a | n/a | -US$40m |
| Mar 31 2020 | n/a | n/a | -US$35m |
| Dec 31 2019 | US$2m | US$430k | -US$27m |
報酬と市場: Lloydの 総報酬 ($USD 4.99M ) は、 US市場 ($USD 649.07K ) の同規模の企業の平均を上回っています。
報酬と収益: Lloydの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Lloyd Segal (60 yo)
8.2yrs
在職期間
US$4,991,804
報酬
Mr. Lloyd Mitchell Segal serves as Director at HotKnot Therapeutics, Inc. Mr. Segal has been the Chief Executive Officer, President and Director of Repare Therapeutics Inc. since September 2016. Mr. Segal...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 8.2yrs | US$4.99m | 0.28% $ 331.2k | |
| Executive VP & CFO | 5.1yrs | US$1.93m | 0.034% $ 40.5k | |
| Executive VP & Chief Medical Officer | 5.5yrs | US$2.09m | 0.47% $ 561.4k | |
| Co-Founder | no data | データなし | データなし | |
| Co-Founder | no data | データなし | データなし | |
| Co-Founder | no data | データなし | データなし | |
| Executive VP & Chief Scientific Officer | 5.5yrs | US$1.83m | 0.098% $ 116.7k | |
| Executive Vice President of Human Resource | 1.5yrs | データなし | 0.0037% $ 4.4k | |
| Executive Vice President of Discovery | 8.4yrs | データなし | 0.055% $ 65.8k | |
| Executive VP | 2.8yrs | データなし | 0.0092% $ 11.0k |
5.5yrs
平均在職期間
53yo
平均年齢
経験豊富な経営陣: RPTXの経営陣は経験豊富で経験豊富です（平均在職期間は5.5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 8.2yrs | US$4.99m | 0.28% $ 331.2k | |
| Independent Director | 4.4yrs | US$274.74k | 0.0094% $ 11.2k | |
| Independent Director | 5.2yrs | US$265.41k | 0% $ 0 | |
| Independent Director | 1.4yrs | US$664.86k | 0% $ 0 | |
| Independent Director | less than a year | データなし | データなし | |
| Independent Director | 5yrs | US$265.31k | 0% $ 0 | |
| Independent Chairman | 3.2yrs | US$291.49k | 0.018% $ 21.1k | |
| Independent Director | 5.7yrs | US$272.99k | 0.019% $ 22.5k |
4.7yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: RPTXの 取締役会 は 経験豊富 であると考えられます ( 4.7年の平均在任期間)。